Dr. Paul Russo, MD – New York, NY

Overview of Dr. Russo

Dr. Paul Russo is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 38 years. He is one of 69 doctors at Memorial Sloan-Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 100 publications and over 500 citings.

Education & Training

  • Memorial Sloan Kettering Cancer Center

    Memorial Sloan Kettering Cancer CenterFellowship, Cancer Biology, 1986 - 1988

  • Memorial Sloan Kettering Cancer Center

    Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1984 - 1988

  • Washington University/B-JH/SLCH Consortium

    Washington University/B-JH/SLCH ConsortiumResidency, Urology, 1981 - 1984

  • Washington University/B-JH/SLCH Consortium

    Washington University/B-JH/SLCH ConsortiumResidency, Surgery, 1979 - 1981

  • Columbia University Vagelos College of Physicians and Surgeons

    Columbia University Vagelos College of Physicians and SurgeonsClass of 1979

Certifications & Licensure

  • NY State Medical License

    NY State Medical License 1988 - 2025

  • NJ State Medical License

    NJ State Medical License 2021 - 2025

  • CT State Medical License

    CT State Medical License 2023 - 2023

  • American Board of Urology Urology

Awards, Honors, & Recognition

  • New York City Best Doctors Castle Connelly, 2000-2016
  • Fellow (FACS) American College of Surgeons
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Importance of Wide Re‐Resection in Adult Spermatic Cord Sarcomas: Report on Oncologic Outcomes at a Single Institution  

    Massimiliano Spaliviero, Kaled M Alektiar, Harry W Herr, Paul Russo, Journal of Surgical Oncology
  • Analysis of Renal Cancer Cell Lines from Two Major Resources Enables Genomics-Guided Cell Line Selection  

    Satish K Tickoo, Paul Russo, A Ari Hakimi, Victor E Reuter, James J Hsieh, Jonathan A Coleman, Michael Chevinsky, Christopher Jakubowski, Andrew G Winer, Nature

Authored Content

Press Mentions

  • PN Risks May Outweigh Benefits in Some CKD Cases

    PN Risks May Outweigh Benefits in Some CKD CasesSeptember 3rd, 2020

  • Does Cytoreductive Nephrectomy Remain an Essential Component of Care for Advanced Renal Cell Carcinoma?

    Does Cytoreductive Nephrectomy Remain an Essential Component of Care for Advanced Renal Cell Carcinoma?June 25th, 2019

  • Factors Affecting Survival After Surgery for Locally Advanced RCC

    Factors Affecting Survival After Surgery for Locally Advanced RCCJune 3rd, 2015

  • Join now to see all

Professional Memberships

Hospital Affiliations

You Might Also Like